Skip to content

Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident

Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03148158
Enrollment
300
Registered
2017-05-10
Start date
2018-01-15
Completion date
2019-06-15
Last updated
2018-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer, Flexible Cystoscopy, Non-muscle Invasive Bladder Cancer (NMIBC), Pain, Postoperative

Keywords

Bladder Cancer, Flexible cystoscopy, Diagnosis

Brief summary

This will be a prospective trial comparing the perspective gross morphological of bladder tumor assessment done by outpatient flexible cystoscopy performed by resident, inpatient rigid cystoscopy done by senior staff and their prediction of the degree of invasion of bladder tumor plus the prediction of the grade compared with the standard pathological result. Also, assessment of the patient reported outcomes after both flexible and rigid cystoscopy will be done. In the long run of the study, the prognostic gross morphology with recurrence, progression and cancer specific survival will be assessed.

Interventions

DEVICECystoscopy

Outpatient flexible cystoscopy and inpatient rigid cystoscopy

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men and women 18 years or older * Denovo or recurrent NMIBC * Bladder mass discovered in hematuria investigation * Willing to share in study

Exclusion criteria

* inability to cooperate with flexible cystoscopic evaluations * cystoscopies for other kind of intervention (e.g., removal of a ureteral stent) * Untreated infections * Other causes of storage or voiding symptoms as untreated benign prostatic hyperplasia (BPH) or interstitial cystitis * Unpassable urethral stricture

Design outcomes

Primary

MeasureTime frameDescription
Assessment of clinical grade and stage of bladder lesions diagnosed by flexible cystoscopy done by urology residents1 yearOutcome measures by histopathological results of bladder biopsy

Secondary

MeasureTime frameDescription
Evaluation of pain perception in patient undergoing flexible or rigid diagnostic cystoscopy1 yearOutcome measures by visual analog scale (VAS) pain score
Assessment of the patient reported outcomes after both flexible and rigid cystoscopy1 yearOutcome measures by Freiburg Index of Patient Satisfaction (FIPS) questionnaire
Assessment of the prognostic value of gross morphology with recurrence, progression2 yearOutcome measures by Number of patients surviving for two year without tumor recurrence will be counted and compared

Countries

Egypt

Contacts

Primary ContactAbdelwahab R. Hashem, Msc
abdelwahab_hashem@yahoo.com01069678979
Backup ContactMohammed H. Zahran, MD
zahranmha@yahoo.com01063338690

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026